Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 30, 2002 FBO #0271
SOLICITATION NOTICE

B -- PROCUREMENT OF DNA RNA TRANSFORMED LYMPHOCYTES AND LYMPHOBLASTOID LINES FOR GENETIC STUDIES

Notice Date
8/28/2002
 
Notice Type
Solicitation Notice
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 
ZIP Code
20852
 
Solicitation Number
N02-CP-31004-50
 
Response Due
11/18/2002
 
Point of Contact
Karen McFarlane, Contracting Officer, Phone (301)435-3782, Fax (301) 480-0241, - Sharon Miller, Contracting Officer, Phone (301) 435-3783, Fax (301) 480-0241,
 
E-Mail Address
km63k@nih.gov, sm103r@nih.gov
 
Description
The Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI) is recompetiting a project which is currently be performed by the American Type Culture Collection under Contract No. N02-CP-81019. The DCEG is seeking a Contractor who will support the various on-going case-control and cohort studies with molecular biology components being conducted by DCEG Investigators. There are four laboratory procedures, or assays to be provided by a single contractor for this acquisition. One or more of these tasks shall be performed on each sample provided by the NCI Project Officer (P.O.). These include: 1) Extraction of DNA from fresh whole blood specimens, transformed lymphoblastoid lines, cultured fibroblasts, tumor specimens, buccal cells, paraffin-embedded tissue, Guthrie cards, cytology preparations, or other biological specimens, as possible from advances in technology; 2) Extraction of RNA from fresh whole blood specimens, transformed lymphoblastoid lines, cultured fibroblasts, tumor specimens, or other biological specimens, as possible from advances in technology; 3) Isolation of lymphocytes, and transformation of lymphocytes and/or cryopreserved whole blood to lymphoblastoid cells using the Epstein-Barr virus (EBV), and 4) Expansion of lymphoblastoid or other types of cell lines up to gram quantities. Approximately 11,000 samples will be submitted to the Contractor for processing during a one year period. Note that some procedures to be performed on these samples are overlapping, resulting in 12,000 procedures estimated to be performed each year. It is anticipated that one incrementally funded, cost reimbursement, completion type contract will be awarded for a base period of three years, and two one year options. The anticipated RFP date is on or about October 18, 2002, with responses due approximately 30 days after the actual issuance date of the RFP. The RFP may be accessed via the NCI Research Contracts Branch (RCB) website: http://rcb.cancer.gov/rcb.internet/ under "Current Requests For Proposals". Award of this project is anticipated by April 30, 2003. All responsible sources may submit a proposal that shall be considered by the NCI. No collect calls will be accepted.
 
Record
SN00152228-W 20020830/020828213810 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.